Richard van Zyl-Smit

About Richard van Zyl-Smit

Richard van Zyl-Smit, With an exceptional h-index of 39 and a recent h-index of 28 (since 2020), a distinguished researcher at University of Cape Town, specializes in the field of respiratory.

His recent articles reflect a diverse array of research interests and contributions to the field:

High-flow nasal oxygen in resource-constrained, non-intensive, high-care wards for COVID-19 acute hypoxaemic respiratory failure: Comparing outcomes of the first v. third waves …

Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons

Household air pollution and risk of pulmonary tuberculosis in HIV-Infected adults

A Respiratory Syncytial Virus (RSV) Prefusion F Candidate Vaccine (RSVPreF3 OA) is Efficacious in Adults≥ 60 Years of Age (YOA)

Respiratory syncytial virus prefusion F protein vaccine in older adults

A Qualitative Exploration of Patients Experiences of Living with Chronic Respiratory Diseases before and after Participating in a Pulmonary Rehabilitation Program at a Tertiary …

Digital Technology and the Future of Interstitial Lung Diseases 1

Home monitoring in interstitial lung diseases

Richard van Zyl-Smit Information

University

Position

___

Citations(all)

6387

Citations(since 2020)

2714

Cited By

4454

hIndex(all)

39

hIndex(since 2020)

28

i10Index(all)

59

i10Index(since 2020)

54

Email

University Profile Page

Google Scholar

Richard van Zyl-Smit Skills & Research Interests

respiratory

Top articles of Richard van Zyl-Smit

High-flow nasal oxygen in resource-constrained, non-intensive, high-care wards for COVID-19 acute hypoxaemic respiratory failure: Comparing outcomes of the first v. third waves …

African Journal of Thoracic and Critical Care Medicine

2024/4/1

Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons

Clinical Infectious Diseases

2024/1/22

Household air pollution and risk of pulmonary tuberculosis in HIV-Infected adults

Environmental Health

2024/1/17

A Respiratory Syncytial Virus (RSV) Prefusion F Candidate Vaccine (RSVPreF3 OA) is Efficacious in Adults≥ 60 Years of Age (YOA)

Pneumologie

2023/3/9

Respiratory syncytial virus prefusion F protein vaccine in older adults

Clinical Infectious Diseases

2024/1/15

A Qualitative Exploration of Patients Experiences of Living with Chronic Respiratory Diseases before and after Participating in a Pulmonary Rehabilitation Program at a Tertiary …

BMJ open

2021

Digital Technology and the Future of Interstitial Lung Diseases 1

LANCET RESPIRATORY MEDICINE

2023/1/1

Home monitoring in interstitial lung diseases

2023/1/1

Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in …

2023/12/31

Le vaccin candidat à base de la protéine F de préfusion du virus respiratoire syncitial (VRS) est efficace chez les adultes≥ 60 ans (RSVPreF3)

Médecine et Maladies Infectieuses Formation

2023/5/1

Comparison of the effects of electronic cigarette vapours and tobacco smoke extracts on human neutrophils in vitro

ERJ Open Research

2023/5/1

Sputum Color as a Marker for Bacteria in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis

2023/5

Ruan Spies
Ruan Spies

H-Index: 4

Matthew Potter
Matthew Potter

H-Index: 1

Richard Van Zyl-Smit
Richard Van Zyl-Smit

H-Index: 28

Disseminated Pulmonary Hydatidosis

2023/5

The Prevalence of IPF and Progressive Pulmonary Fibrosis in South Africa

2023/5

The Nature and Extent of Vaping and Tobacco Use Amongst South African High School Learners

2023/5

Effects of Smoking and Air Pollution on Tuberculosis Development and Treatment Outcomes: A Systematic Review and Meta-analysis

2023/5

Efficacy of once-daily, single-inhaler, fixed-dose combination of mometasone/indacaterol/glycopyrronium in patients with asthma with or without persistent airflow limitation …

Respiratory Medicine

2023/5/1

1936. Efficacy of One Dose of the Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Adults≥ 60 Years of Age Persists for 2 RSV Seasons

Open Forum Infectious Diseases

2023/12

See List of Professors in Richard van Zyl-Smit University(University of Cape Town)